Najeeda Yasmeen

I am an HTA Consultant with over nine years of experience supporting and delivering health technology assessment (HTA) submissions and evidence generation activities across a range of therapeutic areas.

I have supported multiple HTA submissions, contributing to the design of evidence generation strategies and the development of robust, transparent evidence packages to inform decision-making.

I have extensive experience conducting systematic literature reviews (SLRs), indirect treatment comparison (ITC) feasibility assessments, and network meta-analyses (NMAs), across several disease areas including ulcerative colitis, idiopathic pulmonary fibrosis (IPF), and progressive pulmonary fibrosis (PPF). I have also contributed to published research in psoriasis, pemphigus, and advanced chronic kidney disease (aCKD).

I am experienced in interpreting and applying HTA evidence requirements, ensuring that analyses are methodologically robust, transparent, and aligned with the expectations of HTA bodies.